Replication of hepatitis C virus in B lymphocytes (CD19+)

Giulia Morsica(Vita-Salute San Raffaele University), Sylvain Mukenge(Office of Infectious Diseases), Roberto Novati, Lucia Lopalco(Vita-Salute San Raffaele University), Giuseppe Tambussi(San Raffaele University of Rome), Giovanni Sitia(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University)
PubMed
August 1, 1999
Cited by 65

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328